Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics, US Genomics to Develop miRNA-Based Test for Lung Cancer

NEW YORK, May 24 (GenomeWeb News) - Rosetta Genomics and US Genomics today said that they will co-develop an microRNA-based, non-invasive early-detection test for lung cancer.

 

The collaboration will pair US Genomics' Trilogy 2020 platform and Direct miRNA assay with Rosetta Genomics' microRNAs to create a molecular diagnostic that uses a blood sample to identify lung cancer, according to the firms.

Financial details were not discussed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.